NCT00642603 A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00642577 A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE3
NCT00639327 Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00614965 Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV Status COMPLETED Phase PHASE2
NCT00597402 Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas Status COMPLETED Phase PHASE2
NCT00590031 Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. Status COMPLETED Phase PHASE2
NCT00577109 A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. Status WITHDRAWN Phase PHASE2
NCT00563316 Effect of Panitumumab on the Pharmacokinetics of Irinotecan Status COMPLETED Phase PHASE1
NCT00551213 A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) Status COMPLETED Phase PHASE2
NCT00545545 Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00540943 Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00539877 Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding Status COMPLETED Phase PHASE1
NCT00522665 Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00507143 Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan Status UNKNOWN Phase NA
NCT00507091 Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination Status COMPLETED Phase PHASE1
NCT00497497 A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) Status COMPLETED Phase PHASE1
NCT00483834 A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2